Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil
PR Newswire Asia
· "Aiming to offer a Dengue antiviral treatment course in $100 price range"
· Hyundai Bioscience decides to conduct dengue..
Emergency Use Authorization
News and Video Search Results
News coverage
-
California Water Service Group’s First Quarter 2024 Financial Results Benefit from California 2021 General Rate Case Decision
GlobeNewswire
-
InflaRx to Participate in Capital One Securities 1st Annual Biotech/Biopharma Disrupters Event
GlobeNewswire
-
Funding Deterrence: Breakdown Of The Indo-Pacific Supplemental Bill – Analysis
Eurasia Review
-
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID
GlobeNewswire
- More about:
Joe Biden
0 shares
1 views
You might like
Emergency Use Authorization media coverage
Lindis Blood Care Announces Positive Top-Line Results from Clinical Certification Study REMOVE with CATUVAB(R) to Enable Autologous Blood Transfusions in Cancer Surgeries
Accesswire
· *CATUVAB^® procedure enables highly effective removal of malignant cells from intraoperative blood. All clinical endpoints..
-
Lindis Blood Care Announces Positive Top-Line Results from Clinical Certification Study REMOVE with CATUVAB® to Enable Autologous Blood Transfusions in Cancer Surgeries
EQS Group
-
Global COVID-19 Vaccines Research Report 2023-2025 - Licensing and Partnership Deals Worldwide Propel Vaccine Production
GlobeNewswire
-
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization
PR Newswire Asia
-
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting
GlobeNewswire
Advertisement
More coverage
Our Time To Choose: The Institution or The Constitution | The Rob Maness Show EP 334
Rumble
The world changed significantly in early 2020 when the so-called pandemic broke out from Wuhan, China but the biggest changes were..
